All Stories

  1. The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies
  2. Immunomodulation by adoptive regulatory T‐cell transfer improves Coxsackievirus B3‐induced myocarditis
  3. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis
  4. Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
  5. Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men
  6. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
  7. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential
  8. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin